Clinical Trial

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome

CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental diseaseCNM-Au8 also demonstrated rescue…

2 years ago

Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2

– Preclinical data for ARV-393 presented at the European Hematology Association 2024 Annual Congress showed anti-tumor activity in models of…

2 years ago

Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease

•  Established Medium Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial•  DSMB Determination to Proceed with High Dose…

2 years ago

The Multiple Sclerosis Association of America (MSAA) Commemorates 15 Years of Highlighting Artists with MS

CHERRY HILL, N.J., June 20, 2024 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is proud to recognize 15…

2 years ago

“LaToya’s Story” Sheds Light on the Power of Personal Advocacy and the Importance of Health Equity, Wins Two Telly Awards

Mom bravely shares her story to raise awareness of breast cancer and clinical trial participation among Black women. NEW HAVEN,…

2 years ago

RONOVO SURGICAL CLOSES $44M SERIES B FINANCING TO ADVANCE CARINA™ PLATFORM TOWARDS COMMERCIALIZATION AND INTERNATIONAL EXPANSION

SHANGHAI and ORLANDO, Fla., June 20, 2024 /PRNewswire/ -- Ronovo Surgical, a Shanghai-based medical technology innovator developing novel surgical robotics…

2 years ago

NORTHWELL HEALTH AND THE GALIEN FOUNDATION ANNOUNCE COLLABORATION TO SUPPORT GLOBAL HEALTHCARE INNOVATORS

Collaboration Launches with Opportunity for Prix Galien Award Winners from Around the World to Get Access to Northwell Health's International…

2 years ago

NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company…

2 years ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

ORLANDO, FL / ACCESSWIRE / June 20, 2024 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) provides an update on its Aversa Fentanyl product…

2 years ago

A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model

SHELTON, CT / ACCESSWIRE / June 20, 2024 / NanoViricides, Inc. (NYSE AmerIcan.:NNVC) (the "Company"), a clinical stage company and…

2 years ago